Pharma 2020 To Drive Growth In Pharma R&D and Clinical Trials
Pharma & Healthcare / Russia / Wed 27 Sep, 2017
Russia's Pharma 2020 vision is driving growth within the country's pharmaceutical sector, providing considerable opportunities for drugmakers. The market poses significant growth potential for medicine sales, leading to a significant uptick in foreign investment into production capacity. We note that this will remain firmly within the generic